Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section listing participating states and sites (Alabama, Arizona, California, Colorado, Florida, Illinois, Louisiana, Massachusetts, Minnesota, Missouri, Nevada, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah, Washington). Updated to Revision: v3.3.3.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter now shows Revision: v3.3.2 instead of v3.3.1. No study content or navigation changes are visible.SummaryDifference0.0%

- Check32 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe bottom notice about government funding and operating status was removed. The page still presents all study details and contact information.SummaryDifference0.3%

- Check54 days agoChange DetectedThe updates are limited to UI/layout adjustments with no changes to study data (enrollment, locations, eligibility, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference4%

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.